探索影响超重和肥胖的多方面的因素:一个范围审查
Mohsen Jalilzadeh1, Salime Goharinezhad1
1Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
Frontiers in public health
|April 24, 2025
概括
这次范围审查确定了82个影响肥胖和超重的因素,分为社会文化,经济,技术,环境和政治领域. 社会文化因素显著影响健康行为,指导公共卫生战略.
科学领域:
- 公共卫生 公共卫生
- 健康行为研究 研究健康行为研究
- 流行病学 流行病学
背景情况:
- 肥胖和超重构成重大全球公共卫生挑战,影响个人健康,社区福祉和医疗保健系统.
- 了解这些条件的多方面的决定因素对于有效的管理和干预至关重要.
研究的目的:
- 在社会,技术,环境,经济和政治领域识别和分类影响肥胖和超重的因素.
- 为公共卫生干预设计和肥胖流行病控制战略提供可操作的见解.
主要方法:
- 从包括ProQuest,Web of Science,PubMed和Scopus在内的数据库中对文学进行系统的范围审查,并补充了灰色文学.
- 使用框架分析来检查所选研究中的定性数据.
主要成果:
- 综合包括来自46个国家的121项研究和国际合作.
- 确定了82个超重和肥胖的决定因素,并分为五个领域:社会文化,经济,技术,环境和政治.
- 社会文化因素成为最普遍的类别,突出了它们对生活方式和健康行为的重大影响.
结论:
- 有效的公共卫生干预需要全面了解所有影响因素,特别是社会文化方面.
- 应对肥胖流行病需要采用多部门的方法,整合各种领域和政策目标.
- 跨部门的合作对于应对肥胖和促进社区内改善健康的因素至关重要.
相关概念视频
Dimensions of Health and Illness
The factors influencing the health-illness continuum can be internal or external and may or may not be under conscious control. They are related to the following eight human dimensions, and each dimension is interrelated to one other.
Factors Affecting Illness
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness, disability,...
For instance, risk factors are connected to illness, disability,...
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Bulimia Nervosa
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...


